Objectives
After participating in this educational activity, attendees should be able to:
1. Review the definition and background of harm reduction and demonstrate that it is congruent with the management of patients with other chronic relapsing conditions
2. Discuss clinical cases and how harm reduction can be applied to clinical care in a variety of settings
3. Identify opportunities for integrating harm reduction into your own practice
Faculty
Laura Kehoe, MD Medical Director, MGH Substance Use Disorder, Bridge Clinic
Assistant Professor of Medicine, Harvard Medical School
Faculty Disclosure
None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.
Dr. Kehoe has the following disclosures:
Consultant:
MAP Health Management Peer Recovery Support Services
MCSTAP (Mass Consultation Service for the Treatment of Addiction and Pain)
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC Contact Hours
- 1.00 BCIPE Instructional Hours